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Summary
Ostearthritis (OA) is characterized by focal areas of loss of the articular cartilage in synovial joints, associated with varying degrees of osteo-
phyte formation, subchondral bone change and synovitis. The Asporin (ASPN) gene which encodes a protein of the extracellular cartilage
matrix contains a triplet repeat encoding for aspartic acid (D) within exon 2 The D14 allele was found associated with knee and hip osteoar-
thritis in case-control study in the Japanese population. Genotyping Greek knee OA patients for the D repeats we determined that the D15
allele could be considered a risk allele for our population.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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jor contributors to the onset and progression of primary oste-
oarthritis (OA)1,2. OA is characterized by focal areas of loss
of the articular cartilage in synovial joints, associated with
varying degrees of osteophyte formation, subchondral
bone change and synovitis3. The integrity of the joint is dam-
aged because of an imbalance between degradation and
synthesis of the extracellular cartilage matrix (ECM) through
mechanisms controlled by chondrocytes. Previous studies
implicated genes belonging to the small leucine-rich proteo-
glycan (SLRP) family in the etiology of OA4,5. Asporin
(ASPN) is a protein of the ECM and a member of the
SLRP family of transforming growth factor b (TGFb) -binding
proteins. A study has recently been reported by a Japanese
group concerning the association of the ASPN gene with
knee OA (KOA)6. The gene contains a triplet repeat within
exon 2, coding for a polymorphic stretch of aspartic acid res-
idues in the N-terminal region of the protein. This repeat poly-
morphism (D-repeat) has 10 alleles encoding 10e19
residues, with the D13 allele being most common. In
a caseecontrol association study of Japanese hip (HOA)
and KOA patients and control individuals, it was found that
the D14 allele was a risk factor for OA and the D13 allele
had a protective effect (signiﬁcantly underrepresented in pa-
tients). Their ﬁndings prompted us to test the global rele-
vance of the association by genotyping patients of Greek
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2005.60origin. The D13 allele ﬁnding was replicated in our study
and we report that a different allele (D15) was associated
with KOA in Greek patients. Nevertheless when known risk
factors such as BMI were included, statistical signiﬁcance
was lost for the D15 results. Therefore we think that ASPN
remains a candidate risk factor for KOA in Caucasian
populations.
We conducted a caseecontrol study. The osteoarthritic
group consisted of 158 patients, 138 women (mean age
68.1 8.2; range 48e92 years) and 20 men (mean age
72.4 5.8; range 62e85 years). All of them had undergone
total knee replacement, meaning that all of them suffered
from severe KOA, which is deﬁned by a KellgreneLawrence
score 2 and were randomly selected. None of them had
evidence of arthritis due to other disease. The control pop-
ulation consisted of 193 subjects, 137 women (mean age
68 10.9; range 44e87 years) and 56 men (mean age
70.2 9; range 46e88 years), who had undergone treat-
ment for injuries and fractures. More explicitly 159 controls
had injuries (e.g., tendon ruptures, haematomas, concus-
sions, etc.) and 34 had fractures. Only seven were hip
transtrochanteric fractures due to osteoporosis. Detailed
clinical data of OA and control population regarding grade
of physical demand classiﬁcation, KellgreneLawrence
score, BMI (determined at the time of recruitment), age of
menarche and menopause were collected (Supplementary
tables 1 & 2). All individuals were of Greek origin living in
the district of Thessaly of Central Greece. The study was
approved by the ethics committees of the participating
institutions.
The methodology for DNA extraction, determination of the
repeat polymorphisms, and DNA sequencing was as previ-
ously described7. UsingPrimer3 software (http://www.justbio.
com) the following primers were designed for the purposes of9
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Allelic frequencies of the D-repeat polymorphism of ASPN in Greek individuals
Allele D12 D13 D14 D15 D16 D17 D18 D19 Total
Case (N¼ 155) Count 20 118 47 84 20 11 6 4 310
Frequency (%) 6.5 38.1 15.2 27.1 6.5 3.5 1.9 1.3 100
Control (N¼ 190) Count 17 189 53 74 30 16 0 1 380
Frequency (%) 4.5 49.7 13.9 19.5 7.9 4.2 0 0.3 100the polymerase chain reaction (PCR) ampliﬁcation:AspFOR:
Cy5.5 CTTTGTGCTCTGCCAAACCCT and AspREV: AAAT
GGACACATTGGAAACAGATCAAATGG. Six DNA samples
(three from patients and three from controls) were degraded
and yielded no result.
We assessed association using c2 test. Odds ratios
(ORs) were calculated by logistic regression analysis with
95% conﬁdence intervals (CIs). We estimated unadjusted
(univariate) OR for various alleles and subsequently in-
cluded in the logistic regression models’ variables known
to be associated with OA. These variables were age, sex,
BMI, menopausal status, grade of physical demand and
knee bending. In all cases, a P value of <0.05 was taken
as signiﬁcant. All statistical analyses were performed by us-
ing STATA 8.0 (Stata Corporation, College Station, TX,
USA).
The allelic frequencies of the D-repeat polymorphism are
summarized in Table I. As in the Japanese population the
most common variant was the D13 in both patients and
controls.
No signiﬁcant difference was observed in the frequency
distribution of the D14 allele (P¼ 0.65). The frequency of
the D13 allele was signiﬁcantly lower in the group of pa-
tients, a statistical signiﬁcance retained after adjustment
for BMI. The D15 and D18 alleles were signiﬁcantly over-
represented in our group of OA patients (P¼ 0.018 and
P¼ 0.008, respectively). The D18 result due to its low
frequency should be considered with caution. When
ORs were adjusted for BMI statistical signiﬁcance was
lost. Nevertheless the D15 variant was signiﬁcantly overrep-
resented relative to the D13 variant in individuals with OA
(P¼ 0.003) even when BMI was used as a covariate
(P¼ 0.038).
Our results (summarized in Table II) partially support
the ﬁndings of the Japanese group. The protective role
of the D13 allele was conﬁrmed but the association of
the D14 allele with KOA was not replicated. A new allele,
Table II
Association of the D-repeat polymorphism in ASPN with KOA in
Greek individuals
P value OR* 95% CIs
D13 vs others 0.002 0.62 0.46e0.84
D14 vs others 0.65 1.1 0.72e1.69
D15 vs others 0.018 1.54 1.07e2.2
D18 vs others 0.008 y y
D13 vs D15 0.003 1.82 1.23e2.68
D13 vs others (*BMI) 0.014 0.64 0.45e0.91
D15 vs others (*BMI) 0.149 1.35 0.9e2.04
D15 vs D13 (*BMI) 0.038 1.62 1.03e2.56
*Groups compared case vs control.
yOR and CIs could not be calculated.D15, was associated with the disease. A number of func-
tional studies were conducted by the Japanese group6.
These provided a possible mechanism of how the D-re-
peat polymorphism could inﬂuence susceptibility to OA:
ASPN inhibited TGFb signaling and therefore indirectly in-
hibited the expression of genes encoding aggrecan and
type II collagen, critical components of the articular carti-
lage ECM. D14-encoded ASPN, compared to D13, D16
and D17 alleles, had the strongest inhibitory effect there-
fore leading to a more structurally compromised cartilage.
The functional properties of the D15 allele have not yet
been examined and it remains to be shown if they are
similar to those of the D14 allele. A question to be ad-
dressed is how exactly does the size of the D-repeat in-
ﬂuence ASPN activity. Does it bind directly to TGFb or
does it alter the conformational structure of the protein?
In conclusion the role of ASPN in OA seems promising
but the importance of these associations has to be con-
ﬁrmed by independent studies in larger samples and dif-
ferent ethnic groups.
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